InMode - INMD Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INMD shares.
View INMD analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 12 month target prices for InMode's stock. Their INMD share price forecasts range from $40.00 to $60.00. On average, they anticipate the company's stock price to reach $46.33 in the next twelve months. This suggests a possible upside of 55.3% from the stock's current price.
View analysts price targets for INMD or view top-rated stocks among Wall Street analysts.

InMode's stock was trading at $35.70 on January 1st, 2023. Since then, INMD stock has decreased by 16.4% and is now trading at $29.83.
View the best growth stocks for 2023 here.

InMode saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 4,810,000 shares, an increase of 7.4% from the February 13th total of 4,480,000 shares. Based on an average daily volume of 1,440,000 shares, the days-to-cover ratio is presently 3.3 days.
View InMode's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our INMD earnings forecast.

InMode Ltd. (NASDAQ:INMD) released its quarterly earnings results on Tuesday, October, 26th. The healthcare company reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.05. The healthcare company earned $94.18 million during the quarter, compared to analysts' expectations of $89.38 million. InMode had a trailing twelve-month return on equity of 38.15% and a net margin of 35.56%. InMode's quarterly revenue was up 57.7% on a year-over-year basis. During the same period last year, the company posted $0.31 earnings per share.

ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include BlueStar Israel Technology ETF (ITEQ), ARK Israel Innovative Technology ETF (IZRL), iShares MSCI Israel ETF (EIS), VanEck Israel ETF (ISRA) and BlackRock Future Innovators ETF (BFTR).Vident International Equity Strategy ETF (VIDI).

InMode's stock split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were issued to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode updated its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided earnings per share (EPS) guidance of $2.58-$2.60 for the period, compared to the consensus estimate of $2.64. The company issued revenue guidance of $525.00 million-$530.00 million, compared to the consensus revenue estimate of $522.72 million.

1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL).

(INMD) raised $75 million in an initial public offering on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager.

InMode trades on the NASDAQ under the ticker symbol "INMD."

InMode's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (2.67%), Millennium Management LLC (2.30%), American Century Companies Inc. (1.85%), William Blair Investment Management LLC (1.73%), Meitav Dash Investments Ltd. (1.34%) and Man Group plc (1.10%).

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INMD stock can currently be purchased for approximately $29.83.

InMode (NASDAQ:INMD) has a market capitalization of $2.48 billion and generates $454.27 million in revenue each year. The healthcare company earns $161.52 million in net income (profit) each year or $1.90 on an earnings per share basis.

The company employs 362 workers across the globe.

InMode's mailing address is TAVOR BUILDING SHAAR YOKNEAM POB 533, YOKNEAM L3, 2069200. The official website for the company is www.inmodemd.com. The healthcare company can be reached via phone at 972-4909-7470 or via email at ir@inmodemd.com.